Drug Product Registration and Regulatory Requirements in Australia (TGA)

Authors

  • Praveen Agarwal Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, Karnataka, India
  • Mudit Dixit Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, Karnataka, India
  • R Narayana Charyulu Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, Karnataka, India
  • Deepak Bhandary Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, Karnataka, India

DOI:

https://doi.org/10.37591/rrjodfdp.v2i1.321

Abstract

The present study aims to understand the drug product regulatory requirements and drug product registration process in Australia. Therapeutic Goods Administration (TGA) is the regulatory authority for Australia and is responsible for regulating medicines and medical devices. However, as known, each country has its own regulatory agency to enforce the rules and regulate the guidelines to market a drug substance and drug product. To get authorization of marketing of drug substance and product in the Australia, market is known as drug substance and product approval. Further, as per TGA regulation, prescription drugs are evaluated by the Drug Safety and Evaluation Branch (DSEB) and there are three categories of applications, commonly known as Category 1: Applications include new chemical entities, new biological entities, new combination products, extension of indications, major and minor variations, and new generics. Category 2: Applications supported by previous approvals and independent evaluation reports, from two acceptable countries. Category 3: Applications involving changes to the quality data of medicines already included on the ARTG. However in the opinion of the TGA, it does not need to be supported by clinical, non-clinical or bioequivalence data. All the information with respect to drug product has been complied in the form of dossiers. Dossier means a set of applications that include the clinical data, administrative information and quality data. To get a marketing authorization of drug product in Australia, the manufacture(s) has to be planned carefully with high quality of documents and supporting data as well as complete submission dossiers as per TGA rules and norms. The role of manufacture of drug product is very vital during the submission of drug product to ensure submission(s) meet the TGA submission rules and requirements in term of dossiers format and content.

 

Keywords: TGA, Drug Approval, Application Category, Dossier, CTD

Downloads

Published

2019-02-26

Issue

Vol. 2 No. 1 (2015)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.